Silencing STAT3 may inhibit cell growth through regulating signaling pathway, telomerase, cell cycle, apoptosis and angiogenesis in hepatocellular carcinoma: Potential uses for gene therapy

Neoplasma

Volumn 58, Issue 2, 2011, Pages 158-164

  Wang, X H ^a   Liu, B R ^a   Qu, B ^a   Xing, H ^a   Gao, S L ^a   Yin, J M ^a   Wang, X F ^a   Cheng, Y Q ^a  

^a THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Apoptosis; Cell cycle; Signaling pathway; STAT3; Telomerase

Indexed keywords

CASPASE 3; CYCLIN A; CYCLIN E; GELATINASE A; GLUCOSE REGULATED PROTEIN 78; HEAT SHOCK PROTEIN 27; PROTEIN P42; PROTEIN P44; SMAD3 PROTEIN; SMALL INTERFERING RNA; STAT3 PROTEIN; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; VASCULOTROPIN A; X LINKED INHIBITOR OF APOPTOSIS; ANGIOGENIC FACTOR; STAT3 PROTEIN, HUMAN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER GENE THERAPY; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE; CELL STRAIN HEPG2; CONTROLLED STUDY; GENE SILENCING; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; PROTEIN EXPRESSION; CHEMISTRY; DRUG ANTAGONISM; FLOW CYTOMETRY; GENE THERAPY; GENETICS; HUMAN; LIVER TUMOR; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANGIOGENESIS INDUCING AGENTS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL LINE, TUMOR; FLOW CYTOMETRY; GENE SILENCING; GENE THERAPY; HUMANS; LIVER NEOPLASMS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TELOMERASE;

EID: 79958273935     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2011_02_158     Document Type: Article

References (40)

1. FUKE H, SHIRAKI K, SUGIMOTO K, TANAKA J, BEPPU T, et al. Jak inhibitor induces S phase cell-cycle arrest and augments TRAIL-induced apoptosis in human hepatocellular carcinoma cells. Biochem Biophys Res Commun 2007; 363: 738-744. doi:10.1016/j.bbrc.2007.09.049
2. BHARADWAJ U, LI M, CHEN C, YAO Q. Mesothelin-induced pancreatic cancer cell proliferation involves alteration of cyclin E via activation of signal transducer and activator of transcription protein 3. Mol Cancer Res 2008; 6: 1755-1765. doi:10.1158/1541-7786.MCR-08-0095
3. KUSABA M, NAKAO K, GOTO T, NISHIMURA D, KAWASHIMO H, et al. Abrogation of constitutive STAT3 activity sensitizes human hepatoma cells to TRAIL-mediated apoptosis. J Hepatol 2007; 47: 546-555. doi:10.1016/j.jhep.2007.04.017
4. FOSSEY SL, LIAO AT, MCCLEESE JK, BEAR MD, LIN J, et al. Characterization of STAT3 activation and expression in canine and human osteosarcoma. BMC Cancer 2009; 9: 81. doi:10.1186/1471-2407-9-81
5. KUNIGAL S, LAKKA SS, SODADASU PK, ESTES N, RAO JS. Stat3-siRNA induces Fas-mediated apoptosis in vitro and in vivo in breast cancer. Int J Oncol 2009; 34: 1209-1220.
6. CHAU MN, EI TOUNY LH, JAGADEESH S, BANERJEE PP. Physiologically achievable concentrations of genistein enhance telomerase activity in prostate cancer cells via the activation of STAT3. Carcinogenesis 2007; 28: 2282-2290. doi:10.1093/carcin/bgm148
7. SONG H, JIN X, LIN J. Stat3 upregulates MEK5 expression in human breast cancer cells. Oncogene 2004; 23: 8301-8309. doi:10.1038/sj.onc.1208026
8. SONG H, ETHIER SP, DZIUBINSKI ML, LIN J. Stat3 modulates heat shock 27kDa protein expression in breast epithelial cells. Biochem Biophys Res Commun 2004; 314: 143-150. doi:10.1016/j.bbrc.2003.12.048
9. LANDEN CN Jr, LIN YG, ARMAIZ PENA GN, DAS PD, AREVALO JM, et al. Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer. Cancer Res 2007; 67: 10389-10396. doi:10.1158/0008-5472. CAN-07-0858
10. TSAREVA SA, MORIGGL R, CORVINUS FM, WIEDERANDERS B, SCHUTZ A, et al. Signal transducer and activator of transcription 3 activation promotes invasive growth of colon carcinomas through matrix metalloproteinase induction. Neoplasia 2007; 9: 279-291. doi:10.1593/neo.06820
11. QIU Z, HUANG C, SUN J, QIU W, ZHANG J, et al. RNA interference-mediated signal transducers and activators of transcription 3 gene silencing inhibits invasion and metastasis of human pancreatic cancer cells. Cancer Sci 2007; 98: 1099-1106. doi:10.1111/j.1349-7006.2007.00485.x
12. XIE TX, HUANG FJ, ALDAPE KD, KANG SH, LIU M, et al. Activation of stat3 in human melanoma promotes brain metastasis. Cancer Res 2006; 66: 3188-3196. doi:10.1158/0008-5472. CAN-05-2674
13. TAKAHASHI T, ABE H, ARAI H, MATSUBARA T, NAGAI K, et al. Activation of STAT3/Smad1 is a key signaling pathway for progression to glomerulosclerosis in experimental glomerulonephritis. J Biol Chem 2005; 280: 7100-7106. doi:10.1074/jbc.M411064200
14. LONG J, WANG G, MATSUURA I, HE D, LIU F. Activation of Smad transcriptional activity by protein inhibitor of activated STAT3 (PIAS3). Proc Natl Acad Sci USA 2004; 101: 99-104. doi:10.1073/pnas.0307598100
15. LIZA K, MACIEJ K, MATHEW MK, BRENT HC. Knockdown of STAT3 expression by RNAi induces apoptosis in astrocytoma cells. BMC Cancer 2003; 3: 23-32. doi:10.1186/ 1471-2407-3-23
16. HE S, ZHANG D, CHENG F, GONG F, GUO Y. Applications of RNA interference in cancer therapeutics as a powerful tool for suppressing gene expression. Mol Biol Rep 2009; 1: [Epub ahead of print].
17. FENG DY, ZHENG H, TAN Y, CHENG RX. Effect of phosphorylation of MAPK and Stat3 and expression of c-fos and c-jun proteins on hepatocarcinogenesis and their clinical significance. World J Gastroenterol 2001; 7: 33-36.
18. KIM SG, KIM HA, JONG HS, PARK JH, KIM NK, et al. The Endogenous Ratio of Smad2 and Smad3 Influences the Cytostatic Function of Smad3. Molecular Biology of the Cell 2005; 16: 4672-4683. doi:10.1091/mbc.E05-01-0054
19. JANKNECHT R. On the road to immortality: hTERT upregulation in cancercells. FEBS Lett 2004; 564: 9-13. doi:10.1016/S0014-5793(04)00356-4
20. LI H, XU D, LI J, BERNDT MC, LIU JP. Transforming growth factor beta suppresses human telomerase reverse transcriptase (hTERT) by Smad3 interactions with c-Myc and the hTERT gene. J Biol Chem 2006; 281: 25588-25600. doi:10.1074/jbc. M602381200
21. HU B, TACK DC, LIU T, WU Z, ULLENBRUCH MR, et al. Role of Smad3 in the regulation of rat telomerase reverse transcriptase by TGFbeta. Oncogene 2006; 25: 1030-1941. doi:10.1038/sj.onc.1209140
22. ROSS KR, COREY DA, DUNN JM, KELLEY TJ. SMAD3 expression is regulated by mitogen-activated protein kinase kinase-1 in epithelial and smooth muscle cells. Cell Signal 2007; 19: 923-931. doi:10.1016/j.cellsig.2006.11.008
23. SHI YH, DING WX, ZHOU J, HE JY, XU Y, et al. Expression of X-linked inhibitor-of-apoptosis protein in hepatocellular carcinoma promotes metastasis and tumor recurrence. Hepatology 2008; 48: 497-507. doi:10.1002/hep.22393
24. SAKEMI R, YANO H, OGASAWARA S, AKIBA J, NAKASHIMA O, et al. X-linked inhibitor of apoptosis (XIAP) and XIAP-associated factor-1 expressions and their relationship to apoptosis in human hepatocellular carcinoma and non-cancerous liver tissues. Oncol Rep 2007; 18: 65-70.
25. JAFFER S, ORTA L, SUNKARA S, SABO E, BURSTEIN DE. Immunohistochemical detection of antiapoptotic protein X-linked inhibitor of apoptosis in mammary carcinoma. Hum Pathol 2007; 38: 864-870. doi:10.1016/ j.humpath.2006.11.016
26. DAN HC, SUN M, KANEKO S, FELDMAN RI, NICOSIA SV, et al. Akt phosphorylation and stabilization of X-linked inhibitor of apoptosis protein (XIAP). J Biol Chem 2004; 279: 5405-5412. doi:10.1074/jbc.M312044200
27. CARTER BZ, MILELLA M, TSAO T, MCQUEEN T, SCHOBER WD, et al. Regulation and targeting of antiapoptotic XIAP in acute myeloid leukemia. Leukemia 2003; 17: 2081-2089. doi:10.1038/sj.leu.2403113
28. HUANG S, ZHANG F, MIAO L, ZHANG H, FAN Z, et al. Lentiviral-mediated Smad4 RNAi induced anti-proliferation by p16 up-regulation and apoptosis by caspase 3 down-regulation in hepatoma SMMC-7721 cells. Oncol Rep 2008; 20: 1053-1059.
29. NGUYEN TH, MUSTAFA FB, PERVAIZ S, NG FS, LIM LH. ERK1/2 activation is required for resveratrol-induced apoptosis in MDA-MB-231 cells. Int J Oncol 2008; 33: 81-92.
30. Tsuchiya T, TSUNO NH, ASAKAGE M, YAMADA J, YONEYAMA S, et al. Apoptosis induction by p38 MAPK inhibitor in human colon cancer cells. Hepatogastroenterology 2008; 55: 930-935.
31. QUINONES QJ, DE RIDDER GG, PIZZO SV. GRP78: a chaperone with diverse roles beyond the endoplasmic reticulum. Histol Histopathol 2008; 23: 1409-1416.
32. HWANG JH, KIM JY, CHA MR, RYOO IJ, CHOO SJ, et al. Etoposide-resistant HT-29 human colon carcinoma cells during glucose deprivation are sensitive to piericidin A, a GRP78 down-regulator. J Cell Physiol 2008; 215: 243-250. doi:10.1002/jcp.21308
33. RAMSAY RG, CIZNADIJA D, MANTAMADIOTIS T, ANDERSON R, PEARSON R. Expression of stress response protein glucose regulated protein-78 mediated by c-Myb. Int J Biochem Cell Biol 2005; 37: 1254-1268. doi:10.1016/ j.biocel.2004.12.011
34. SKANDRANI D, GAUBIN Y, BEAU B, MURAT JC, VINCENT C, et al. Effect of selected insecticides on growth rate and stress protein expression in cultured human A549 and SH-SY5Y cells. Toxicol In Vitro 2006; 20: 1378-1386. doi:10.1016/j.tiv.2006.06.001
35. FANELLI MA, MONTT-GUEVARA M, DIBLASI AM, GAGO FE, TELLO O, et al. P-Cadherin and beta-catenin are useful prognostic markers in breast cancer patients; beta-catenin interacts with heat shock protein Hsp27. Cell Stress Chaperones 2008; 13: 207-220. doi:10.1007/s12192-007-0007-z
36. CARMELIET P. VEGF as a key mediator of angiogenesis in cancer. Oncology 2005; 69: 4-10. doi:10.1159/000088478
37. DING Y, BOGUSLAWSKI EA, BERGHUIS BD, YOUNG JJ, ZHANG Z, et al. Mitogen-activated protein kinase kinase signaling promotes growth and vascularization of fibrosarcoma. Mol Cancer Ther 2008; 7: 648-658. doi:10.1158/1535-7163. MCT-07-2229
38. WANG M, ZHANG W, CRISOSOMO P, MARKEL T, MELDRUM KK, et al. STAT3 mediates bone marrow mesenchymal stem cell VEGF production. J Mol Cell Cardiol 2007; 42: 1009-1015. doi:10.1016/j.yjmcc.2007.04.010
39. HARA T, MIYAZAKI H, LEE A, TRAN CP, REITER RE. Androgen receptor and invasion in prostate cancer. Cancer Res 2008; 68: 1128-1135. doi:10.1158/0008-5472.CAN-07-1929
40. MORAN DM, MATTOCKS MA, CAHILL PA, KONIARIS LG, MCKILLOP IH. Interleukin-6 Mediates G(0)/G(1) Growth Arrest in Hepatocellular Carcinoma through a STAT3-Dependent Pathway. J Surg Res 2007; 13; Epub ahead of print.